Amanda McFarland, Senior Consultant QRM and Microbiology and James Wamsley, Consultant - Microbiology will be presenting this course.

No matter where you are in the pharmaceutical supply chain, INTERPHEX delivers relevant solutions through curated education sessions, networking and over 500 global suppliers to source quality product and services.

Join ValSource instructors, Marc Glogovsky, Amanda McFarland, Patrick Mains, and James Wamsley.

Join Amanda McFarland, ValSource Senior QRM Consultant and PDA co-chair at the 2023 PDA Annual Meeting in New Orleans, LA — April 3-5.

Whether you are producing biologic drug substance, conducting sterile fill-finish operations, or entering into cell and gene therapy, this meeting will provide the latest information to help your organization have the knowledge and agility needed to meet the needs of the patients we serve.

Amanda McFarland, Senior QRM Consultant at Valsource is speaking at the 2023 ISPE Aseptic Conference, March 6-7 2023 in North Bethesda, MD.

Join us for the 2023 PDA Contamination Control Strategies Workshop — March 1 & 2 in Raleigh, NC.

You're invited to the 2023 PDA Annex 1 Workshop — Feb 27 & 28 in Raleigh, NC.

See you at the ISPE CaSA 30th Annual Life Sciences Technology Show - Feb 28, 2023 at the Raleigh, NC Convention Center!

Our very own James Vesper, PhD, MPH, Director Learning Solutions discusses "Human Error as a Root Cause" as part of the "Current Hot GMP Topics

This year's theme: “Construction in a VUCA World: Volatility | Uncertainty | Complexity | Ambiguity.

In this one-day training course with ValSource's own, Jim Vesper, participants will examine regulatory expectations regarding investigations where people are involved in the deviation, models and tools used in the transportation industry. They will also learn how the brain and certain actions can set up a person to make a mistake.

2022 Annual Environmental Monitoring Training Program – A Practical Approach to Design, Qualification and Implementation of a Robust and Compliant Environmental Monitoring and Trending Program with Paula Peacos

Darius Pillsbury (Senior Consultant) and Stephen Langille (Senior Microbiology Consultant) Presentation: Are You Ready for Annex 1? Points to Consider When Doing an Annex 1 Self-Assessment -- A Comprehensive Review of Annex 1 History, Revisions and the Latest Draft to Ensure Readiness for Annex 1 Compliance & Understanding Its Potential Global Regulatory Impact

Stephen Langille, Ph.D. (Senior Microbiology Consultant) Presentation -- Burkholderia cepacia Complex Organisms: The New General Chapter USP <60> Microbiological Examination of Non-Sterile Products Tests for Burkholderia cepacia Complex & FDA’s Position on Bcc.

Scheduled December 7 at 10 am PRT/9 am EST, James Vesper a member of the VS consulting team, will be presenting "An Example of Using a Risk-Based Approach for Data Integrity." His presentation will discuss: When do you “verify” an action? What does “verify” really mean? How does verify compare to actions like review or check? This presentation looks at what the US, EU, and PIC/S Good Manufacturing Practice regulations say about confirming that an action or activity has taken place using a risk-based approach that supports data integrity.

Tired of TEAMS? Zoomed-Out? ValSource’s Training Team is here to connect, face-to-face. You’re ready for real interactions, and we are too. Get to know colleagues, discuss important topics, and learn more – together.

Discover novel approaches and best practices for tackling current industry contamination control challenges at the 4th Annual SMi Pharmaceutical Microbiology West Coast (Virtual) Conference.

Ensure compliance when you transform your root cause analysis and corrective and preventive action (CAPA) investigations. Join James Vesper, Director, ValSource Learning Solutions, on a discussion exploring risk-based alternatives when a definitive root cause can’t be determined.

Learn ways to conduct better investigations and corrective actions. This workshop examines a defined, logical process that can be applied to investigations that are performed in the drug, biotech, and medical device industries.

Improving, Modernizing, Transforming – Process Validation Gets a (much needed) Upgrade